Completed Heart, Stroke & Blood Digestion, Kidneys & Other Organs
Development of a cytotopically-modified antithrombotic agent for prevention of acute intra-graft thrombosis in transplantation
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at King's College London.
View the original record at the funder ↗
Researchers
Anthony Dorling (EPMC Awardee)Richard Smith (EPMC Awardee)Steven Sacks (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Development of a novel small molecule for the prevention of allogeneic bone marrow stem cell transplant rejection
Interdisciplinary Training Programme in Translational Medicine & Therapeutics at Imperial College: 'Development of an antibody-targeted PET imaging strategy for the detection of oxidised low density lipoprotein in atherosclerosis'.
Wellcome Trust PhD Programme for Clinicians at Imperial College London: 'Development of novel biomaterials to aid stem cell transplantation following myocardial infarction.'
Development of a novel bioartificial device for the treatment of patients with liver failure
Scottish Consortium Translational Medicine and Therapeutics Programme: 'Bone marrow derived cell therapy to enhance regeneration of the liver following resection'.
Original classification
Translation AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know